Monitoring tricyclazole residues in rice paddy watersheds

Pesticide application to rice paddies may affect the quality of environmental resources such as groundwater and surface water. The distribution of residues of tricyclazole, an environmentally persistent fungicide used widely in Italy, was monitored in the network of surface water bodies surrounding the main rice production area in Italy. The location of monitoring sites was based on the potential risk for contamination with tricyclazole. This was determined as a function of the area of rice grown, the geographical distribution of rice crops susceptible to the pest, and sales of tricyclazole. Monitoring sites were also located to represent different spatial scales (farm, catchment and basin). For water samples taken shortly after application in July and August, the highest concentrations of tricyclazole were measured at the farm sites. However, residues were also detected at the catchment and basin scale. The 95% of the measured residue levels was below 9.80, 1.20 and 1.15 microg l(-1), at the farm, catchment and basin scales, respectively. In sediment, tricyclazole residues were detected in 12 out 176 samples collected with the 95% of the measured residue levels below the concentration of 0.03 mg kg(-1). Residues were sporadically detected in samples taken after the crop was harvested in November and December. Variables such as the scale of sampling, the season and the year, were significant in determining pesticide residue distribution. The type of water body was less significant.     

The nuchal translucency and the fetal heart: a literature review

In this overview the current knowledge of the relationship between an increased nuchal translucency (NT) measurement and fetal heart structure and function in chromosomally normal fetuses is reviewed. Relevant pathophysiological theories behind the increased NT are discussed. Fetuses with an increased NT have an increased risk for congenital heart disease (CHD) with no particular bias for one form of CHD over another. This risk increases with increasing NT measurement. Although the NT measurement is only a modestly effective screening tool for all CHD when used alone, it may indeed be effective in identifying specific CHD “likely to benefit” from prenatal diagnosis. The combination of an increased NT, tricuspid regurgitation and an abnormal ductus venosus (DV) Doppler flow profile, is a strong marker for CHD. A fetal echocardiogram should be performed at 20 weeks' gestation in fetuses with an NT ≥ 95th percentile but < 99th percentile. When the NT measurement is ≥ 99th percentile, or when tricuspid regurgitation and/or an abnormal DV flow pattern is found along with the increased NT, an earlier echocardiogram is indicated, followed by a repeat scan at around 20 weeks' gestation. The resultant increased demand for early fetal echocardiography and sonographers with this special expertise needs to be planned and provided for. Copyright © 2009 John Wiley & Sons, Ltd.